Agency, ambivalence and authenticity: The many ways in which anorexia nervosa can affect autonomy

About this resource

On the basis of detailed interviews of females aged between fifteen and twenty-six years with a diagnosis of anorexia nervosa we argue that the autonomy of people with this condition may be severely compromised in four ways, particularly in relation to eating and weight. First there are problems with agency. Second, affective components, particularly anxiety, can dominate beliefs such that the grounds for making a decision may differ from the reasons given in justification. Third, the interactions between the affective components and the objective evidence lead to substantial inner conflicts with resulting lack of stability in preferences and beliefs. Fourth, this lack of stability leads to concerns around identity and authenticity. We argue that some of the ways in which autonomy is compromised reduce competence to decide on treatment. We suggest that these results may be relevant to other mental disorders and have clinical and policy implications.

AuthorCraigie, Jillian; Hope, Tony; Tan, Jacinta; Stewart, D. Anne & McMillan, John
JournalInternational Journal of Law in Context
Volume9(1):20-36
Year2013

See also

Failure to feed patients with anorexia nervosa and other perils and perplexities in the medical care of eating disorder patients

A 28 year old woman with anorexia nervosa was sent to an emergency room by her gastroenterologist for weakness and nausea following placement of a percutaneous endoscopic gastrostomy (PEG) tube, with a plan for admission to the hospital.

Read more

A case series evaluation of the Maudsley Model for treatment of adults with anorexia nervosa

OBJECTIVE: Outpatient psychotherapy has been largely unsuccessful in assisting adults with anorexia nervosa (AN) to achieve weight restoration.

Read more

Metabolic state and value-based decision-making in acute and recovered female patients with anorexia nervosa

Background: Patients with anorexia nervosa forgo eating despite emaciation and severe health consequences.

Read more

Investigating the effectiveness, safety and tolerability of quetiapine in the treatment of an- orexia nervosa in young people: a pilot study

To investigate the safety and tolerability of the atypical antipsychotic quetiapine in anorexia nervosa patients, and to determine the effect of quetiapine treatment on anorexic psychopathology and other key outcome measures including weight and body image, we conducted a naturalistic, open-label, 12-week randomized controlled trial of low-dose (100-400 mg/day) quetiapine treatment versus treatment as usual in 33 anorexia nervosa patients from our Eating Disorder Clinics.

Read more

Help us improve!

Give us feedback!

We will continue throughout 2020 to update and improve the NEDC website and welcome any feedback you may have on the site.

Provide feedback